Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $8.98 Million - $9.8 Million
-29,041 Closed
0 $0
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $2.54 Million - $3.09 Million
9,684 Added 50.03%
29,041 $9.07 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $1.12 Million - $1.36 Million
4,175 Added 27.5%
19,357 $5.5 Million
Q4 2023

Oct 21, 2024

BUY
$255.7 - $288.46 $2.02 Million - $2.27 Million
7,882 Added 107.97%
15,182 $4.37 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $2.02 Million - $2.27 Million
7,882 Added 107.97%
15,182 $4.37 Million
Q3 2023

Oct 21, 2024

BUY
$218.65 - $271.46 $940,195 - $1.17 Million
4,300 Added 143.33%
7,300 $1.96 Million
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $1.86 Million - $2.31 Million
-8,496 Reduced 53.79%
7,300 $1.96 Million
Q2 2023

Oct 21, 2024

SELL
$214.27 - $253.37 $2.84 Million - $3.36 Million
-13,245 Reduced 45.61%
15,796 $3.51 Million
Q2 2023

Oct 21, 2024

SELL
$214.27 - $253.37 $2.74 Million - $3.24 Million
-12,796 Reduced 81.01%
3,000 $666 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $3.38 Million - $4 Million
15,796 New
15,796 $3.51 Million
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $516,706 - $582,751
2,302 Added 111.75%
4,362 $983,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $680,363 - $757,126
-2,949 Reduced 58.87%
2,060 $501,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $509,802 - $563,975
-2,325 Reduced 31.7%
5,009 $1.21 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $1.46 Million - $1.67 Million
7,334 New
7,334 $1.65 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.58 Million - $1.85 Million
-7,452 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $1.51 Million - $1.68 Million
-6,481 Reduced 46.52%
7,452 $1.82 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $3.09 Million - $3.6 Million
13,933 New
13,933 $3.47 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.